Ultragenyx Pharmaceutical

RARE49

$50.63arrow_drop_up0.17%$0.08

RARE49

$50.63

arrow_drop_up0.17%$0.08

Performance History

Key Stats
Open	$49.33
Prev. Close	$50.52
EPS	-7.37
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	49.33	52.50
52 Week Range	31.52	60.37

Ratios







EPS	-7.37

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Ultragenyx Pharmaceutical (RARE)

Ultragenyx Pharmaceutical Inc (RARE) is a biopharmaceutical company focused on the development and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases. The company's mission is to bring transformative therapies to patients with limited or no treatment options. With a market capitalization of over $10 billion, Ultragenyx is one of the leading companies in the rare disease space.

Ultragenyx's stock price history reflects the company's growth and development over the years. Starting from its initial public offering (IPO) in 2014, the stock has experienced both ups and downs, as is common in the biotech industry. However, it has demonstrated resilience and shown significant growth potential. The company has been able to attract investors with its innovative pipeline and promising drug candidates.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Emil D. Kakkis M.D., Ph.D.
Headquarters: Novato
Employees: 1311
Exchange: NASDAQ

add Ultragenyx Pharmaceutical to watchlist

Keep an eye on Ultragenyx Pharmaceutical

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Ultragenyx Pharmaceutical 's (RARE) price per share?

The current price per share for Ultragenyx Pharmaceutical (RARE) is $50.63. The stock has seen a price change of $0.09 recently, indicating a 0.18% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Ultragenyx Pharmaceutical (RARE)?

For Ultragenyx Pharmaceutical (RARE), the 52-week high is $60.37, which is 19.23% from the current price. The 52-week low is $31.52, the current price is 60.63% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Ultragenyx Pharmaceutical (RARE) a growth stock?

Ultragenyx Pharmaceutical (RARE) has shown an average price growth of -3.17% over the past three years. It has received a score of 38 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Ultragenyx Pharmaceutical as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Ultragenyx Pharmaceutical (RARE) stock price performance year to date (YTD)?

As of the latest data, Ultragenyx Pharmaceutical (RARE) has a year-to-date price change of 5.11%. Over the past month, the stock has experienced a price change of -3.43%. Over the last three months, the change has been 1.73%. Over the past six months, the figure is 17.72%. Looking at a longer horizon, the five-year price change stands at 34.95%.

help

Is Ultragenyx Pharmaceutical (RARE) a profitable company?

Ultragenyx Pharmaceutical (RARE) has a net income of -$606.64M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 89.59% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -79.14% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $434.25M, with a revenue growth rate of 19.52%, providing insight into the company's sales performance and growth. The gross profit is $389.04M. Operating income is noted at -$569.21M. Furthermore, the EBITDA is -$500.94M.

help

What is the market capitalization of Ultragenyx Pharmaceutical (RARE)?

Ultragenyx Pharmaceutical (RARE) has a market capitalization of $4.67B. The average daily trading volume is 50.32, indicating the stock's liquidity and investor engagement.